Adar Poonawalla: Rise of the Vaccine Prince
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Tuesday
January 31, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
TUESDAY, JANUARY 31, 2023
Adar Poonawalla: Rise of the Vaccine Prince

Panorama

Nabila Nazrul
06 May, 2021, 11:45 am
Last modified: 06 May, 2021, 09:40 pm

Related News

  • Rally, scientific seminar to prevent cervical cancer held at Labaid Hospital
  • Updated Covid vaccines prevented illness from latest variants -CDC
  • Vaccine misinformation spawns 'pure blood' movement
  • World renowned Vaccinologist Professor Dame Sarah Gilbert visits Incepta Pharma
  • Cancer vaccine hunt makes progress, finally

Adar Poonawalla: Rise of the Vaccine Prince

From 35 exporting countries when Adar joined, today, the Serum sells vaccines to 140 countries

Nabila Nazrul
06 May, 2021, 11:45 am
Last modified: 06 May, 2021, 09:40 pm
A Serum technician checks on coronavirus vaccine production. Photo: Bloomberg 
A Serum technician checks on coronavirus vaccine production. Photo: Bloomberg 

The Serum Institute of India, the most prominent vaccine producer globally, has often made the headlines ever since it began producing Covid-19 vaccines for Oxford-AstraZeneca. After the second wave seized India,  the Serum has once again caught the attention of global media, but for a different reason. 

Its CEO Adar Poonwalla 'fled' India after high influencers threatened him demanding vaccines. Poonwalla has been in London ever since in fear for his life. 

In an interview with Times earlier this week, Poonwalla said he stayed in London for an extended time because "I don't want to go back to that situation… Everything falls on my shoulders, but I can not do it alone. I do not want to be in a situation where you are just trying to do your job, and just because you can't supply the needs of X, Y or Z, you do not want to guess what they are going to do." 

However, after the Indian government recently promised Y category security for Poonwalla, the Serum CEO said he would return to India in a few days. 

So, what was Adar Poonawalla's story behind making Serum the largest vaccine producer in the world? How did the rise of Serum Institute take place? 

We have to take a trip down memory lane to the '60s, when the father of Adar, Cyrus Poonawalla, started this venture.

Father Poonwalla laying the ground 

Cyrus, intending to engage in business with mass-market potential, figured a massive demand for snake bite anti-venoms and tetanus antitoxins in India. Tetanus antitoxin counterbalances tetanus in the bloodstream. 

These anti-venom and antitoxin are produced by injecting horses with a small amount of venom and bacteria. Horses' Serum – the fluid part of blood is harvested and refined into treatments. 

The Poonawallas used to sell retired racehorses to a government institute in Mumbai involved in tetanus vaccine production. It was Cyrus's prudence that he realised he could manufacture it more profitably.  The Serum Institute of India Pvt. Ltd., which he founded in 1966, was soon working on vaccines, too, including the one for tetanus.

In the early '70s, when there was a wave of smallpox and polio elimination worldwide and India introduced measles-mumps-rubella shots, vaccine production in India was largely dependent on government-run labs. 

Rigid bureaucracy, high manufacturing cost, and sleepy service delivery made it difficult for the government to produce vaccines on a large scale. Cyrus leveraged Serum's agile management and lower costs to bag contracts from national and state administrations. 

Under the supervision of father Poonwalla, the Serum Institute continued to grow that the son Poonwalla would take to global leadership in vaccine production once he joined.  

Rise of son Poonwalla, the vaccine prince 

Adar Poonawalla
Adar Poonawalla

Adar Poonawalla, a fresh graduate from the University of Westminster, joined Serum's sales team in 2001.  

At that time, Western manufacturers were producing more complex vaccines at a higher price which were unaffordable to poorer countries. This left the third world markets open to any provider at a lower cost. 

Adar grabbed the opportunity.  

He travelled different parts of the world and made sure it is Serum that would be providing vaccines all over the world at a lower price. 

From 35 exporting countries, today, the Serum sells vaccines to 140 countries.

For Adar, It was all about creating capacity as there will be a never-ending demand for vaccines worldwide. For the developed world's manufacturers, making basic vaccines for emerging markets had a low-profit margin. So, they were not attracted.   

When Adar became the CEO of Serum in 2011, he anticipated the growing vaccine demand accurately and gradually increased Serum's production footprint. He built a more robust manufacturing line and multiplied its capacity. 

India' second wave, and the vaccine prince in water 

Today Serum Institute of India is one of the top producers of Covid-19 vaccines.  With Oxford's method and AstraZeneca's finance and distribution channel, Adar managed the deal for Serum to produce 400 million doses of Covishield, the local name for the Oxford/AstraZeneca vaccine. 

As India has identified more than 20 million Covid-19 cases so far and lost more than 226,169 lives, Serum is the country's resort to get out of the crisis. 

The company produces 70 million doses of Covishield per month now. Notwithstanding, Adar Poonawalla had to be threatened by politicians and business tycoons to secure their jabs. 

The problem started in New Delhi's vaccine procurement strategy. In April, India decided to allow state governments and private hospitals to purchase half of the vaccine stocks. The situation would have been otherwise had the government centralised the distribution. 

Early orders of vaccines from rich country politicians gave manufacturers the confidence to upsurge their production. On the contrary, the Indian government waited for the vaccines to be approved first and then placed orders slowly when the production took place in their own country. 

''They are saying if you don't give us the vaccine, it's not going to be good. It is not foul language. It is the tone. It is the implication of what they might do if I do not comply. It's taking control. It's coming over and basically surrounding the place and not letting us do anything unless we give in to their demands", said Poonawalla in his interview with The Times. 

The COVAX facility backed by the World Health Organization for lower-income countries' vaccine requirements was supposed to be manufactured in Serum, whose production is now on hold. 

Poonawalla is yet to return as the gossip on the Internet continues. In the meantime, the vaccine prince has also indicated he is thinking of expanding Serum's manufacture outside of India.   

Analysis / Top News

Adar Poonawalla / Vaccine / Serum Institute of India

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • The International Monetary Fund (IMF) logo is seen outside the headquarters building in Washington, U.S., September 4, 2018. REUTERS/Yuri Gripas/File Photo
    IMF approves Bangladesh's $4.7 billion loan proposal
  • Despite downturn 3 dozen listed firms plan Tk7,500cr investment
    Despite downturn 3 dozen listed firms plan Tk7,500cr investment
  • Mysterious resignation of SIBL chairman, addl MD
    Mysterious resignation of SIBL chairman, addl MD

MOST VIEWED

  • Leepu realised his love for cars from a young age and for the last 40 years, he has transformed, designed and customised hundreds of cars. Photo: Collected
    'I am not crazy about cars anymore': Nizamuddin Awlia Leepu
  • Spotify is among the tech platforms that saw record growth during Covid lockdowns
Photo: DW
    Could tech layoffs spread to rest of US economy?
  • Photo: Masum Billah/TBS
    How the Padma Bridge motorbike ban spawned a new business
  • TBS illustration
    Where do Shariah-compliant mutual funds stand in Bangladesh
  • Sketch: TBS
    A subsidy war without winners
  • Illustration: TBS
    'The silver lining is that the worst is sort of behind us': Hamid Rashid, UN economist

Related News

  • Rally, scientific seminar to prevent cervical cancer held at Labaid Hospital
  • Updated Covid vaccines prevented illness from latest variants -CDC
  • Vaccine misinformation spawns 'pure blood' movement
  • World renowned Vaccinologist Professor Dame Sarah Gilbert visits Incepta Pharma
  • Cancer vaccine hunt makes progress, finally

Features

Spotify is among the tech platforms that saw record growth during Covid lockdowns
Photo: DW

Could tech layoffs spread to rest of US economy?

14m | Panorama
Leepu realised his love for cars from a young age and for the last 40 years, he has transformed, designed and customised hundreds of cars. Photo: Collected

'I am not crazy about cars anymore': Nizamuddin Awlia Leepu

24m | Panorama
Photo: Courtesy

The Hawkers: Where minimalism meets motifs

21h | Brands
TBS illustration

Where do Shariah-compliant mutual funds stand in Bangladesh

19h | Panorama

More Videos from TBS

two more factories of the country got platinum certificate.

two more factories of the country got platinum certificate.

11h | TBS Today
Iconic villains of Bollywood

Iconic villains of Bollywood

12h | TBS Entertainment
General knowledge "Gravity"

General knowledge "Gravity"

10h | Videos
Will tanks turn the tide for Ukraine?

Will tanks turn the tide for Ukraine?

11h | TBS World

Most Read

1
Picture: Collected
Bangladesh

US Embassy condemns recent incidents of visa fraud

2
Illustration: TBS
Banking

16 banks at risk of capital shortfall if top 3 borrowers default

3
Bapex calls candidates for job test 9 years after advert!
Bangladesh

Bapex calls candidates for job test 9 years after advert!

4
Photo: Collected
Splash

Hansal Mehta responds as Twitter user calls him 'shameless' for making Faraaz

5
A frozen Beyond Burger plant-based patty. Photographer: AKIRA for Bloomberg Businessweek
Bloomberg Special

Fake meat was supposed to save the world. It became just another fad

6
Representational Image
Banking

Cash-strapped Islami, Al-Arafah and National turn to Sonali Bank for costly fund

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]